Mathematical models of blood coagulation and platelet adhesion: clinical applications.

At present, computer-assisted molecular modeling and virtual screening have become effective and widely-used tools for drug design. However, a prerequisite for design and synthesis of a therapeutic agent is determination of a correct target in the metabolic system, which should be either inhibited or stimulated. Solution of this extremely complicated problem can also be assisted by computational methods. This review discusses the use of mathematical models of blood coagulation and platelet-mediated primary hemostasis and thrombosis as cost-effective and time-saving tools in research, clinical practice, and development of new therapeutic agents and biomaterials. We focus on four aspects of their application: 1) efficient diagnostics, i.e. theoretical interpretation of diagnostic data, including sensitivity of various clotting assays to the changes in the coagulation system; 2) elucidation of mechanisms of coagulation disorders (e.g. hemophilias and thrombophilias); 3) exploration of mechanisms of action of therapeutic agents (e.g. recombinant activated factor VII) and planning rational therapeutic strategy; 4) development of biomaterials with non-thrombogenic properties in the design of artificial organs and implantable devices. Accumulation of experimental knowledge about the blood coagulation system and about platelets, combined with impressive increase of computational power, promises rapid development of this field.

[1]  F I Ataullakhanov,et al.  A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. I. The model description. , 1996, Thrombosis research.

[2]  Clement Kleinstreuer,et al.  Comparison of blood particle deposition models for non-parallel flow domains. , 2003, Journal of biomechanics.

[3]  Andreas Schwienhorst,et al.  Thrombin inhibitors identified by computer-assisted multiparameter design. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F I Ataullakhanov,et al.  A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results. , 1996, Thrombosis research.

[5]  Clement Kleinstreuer,et al.  Numerical simulation of wall shear stress conditions and platelet localization in realistic end-to-side arterial anastomoses. , 2003, Journal of biomechanical engineering.

[6]  M A Khanin,et al.  A mathematical model of the kinetics of blood coagulation. , 1989, Journal of theoretical biology.

[7]  Diran Basmadjian,et al.  A mathematical model of thrombin production in blood coagulation, Part I: The sparsely covered membrane case , 1994, Annals of Biomedical Engineering.

[8]  B. Dahlbäck,et al.  Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases , 2005, Journal of internal medicine.

[9]  J M Nigretto,et al.  In vitro factor XI activation mechanism according to an optimized model of activated partial thromboplastin time test , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  P. Tracy,et al.  Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. , 1990, The Journal of biological chemistry.

[11]  C Kleinstreuer,et al.  Simulation of particle-hemodynamics in a partially occluded artery segment with implications to the initiation of microemboli and secondary stenoses. , 1998, Journal of biomechanical engineering.

[12]  K. R. Rajagopal,et al.  A mathematical model to describe the change in the constitutive character of blood due to platelet activation , 2002 .

[13]  T David,et al.  Platelet deposition in stagnation point flow: an analytical and computational simulation. , 2001, Medical engineering & physics.

[14]  M. Sefton,et al.  A model of thrombin inactivation in heparinized and nonheparinized tubes with consequences for thrombus formation. , 1986, Journal of biomedical materials research.

[15]  C. Sprung,et al.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.

[16]  G. Broze,et al.  Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* , 1998, The Journal of Biological Chemistry.

[17]  James F. Antaki,et al.  Computational Simulation of Platelet Deposition and Activation: I. Model Development and Properties , 1999, Annals of Biomedical Engineering.

[18]  J. Birktoft,et al.  Structure and Biology of Tissue Factor Pathway Inhibitor , 2001, Thrombosis and Haemostasis.

[19]  N. O. Solum,et al.  Procoagulant expression in platelets and defects leading to clinical disorders. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Ezekowitz,et al.  Tissue factor pathway inhibitors as a novel approach to antithrombotic therapy. , 2003, Drug news & perspectives.

[21]  Sriram Krishnaswamy,et al.  Formation of Factors IXa and Xa by the Extrinsic Pathway , 2004, Journal of Biological Chemistry.

[22]  K. Mann,et al.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation. , 1994, The Journal of biological chemistry.

[23]  K. Mann,et al.  Blood coagulation in hemophilia A and hemophilia C. , 1998, Blood.

[24]  K. Mann,et al.  A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition. , 1999, Biochemistry.

[25]  Aaron L Fogelson,et al.  Platelet-wall interactions in continuum models of platelet thrombosis: formulation and numerical solution. , 2004, Mathematical medicine and biology : a journal of the IMA.

[26]  Thierry Langer,et al.  Pharmacophore Identification, in Silico Screening, and Virtual Library Design for Inhibitors of the Human Factor Xa. , 2005 .

[27]  J. Oliver,et al.  Platelet activity of high‐dose factor VIIa is independent of tissue factor , 1997, British journal of haematology.

[28]  K Affeld,et al.  Mathematical Model of Platelet Deposition under Flow Conditions , 2004, The International journal of artificial organs.

[29]  James F. Antaki,et al.  Computational Simulation of Platelet Deposition and Activation: II. Results for Poiseuille Flow over Collagen , 1999, Annals of Biomedical Engineering.

[30]  E F Leonard,et al.  THE ROLE OF CONVECTION AND DIFFUSION ON PLATELET ADHESION AND AGGREGATION , 1972, Annals of the New York Academy of Sciences.

[31]  H C Hemker,et al.  Simulation model for thrombin generation in plasma. , 1991, Haemostasis.

[32]  S. Baldwin,et al.  Coagulation on biomaterials in flowing blood: some theoretical considerations. , 1997, Biomaterials.

[33]  D. Basmadjian.  The hemodynamic and embolizing forces acting on thrombi--II. The effect of pulsatile blood flow. , 1986, Journal of biomechanics.

[34]  D. Hoppensteadt,et al.  Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders , 2001, Expert opinion on investigational drugs.

[35]  F I Ataullakhanov,et al.  Contact Activation of Blood Coagulation : Trigger Properties and Hysteresis Kinetic Recognition of Foreign Surfaces upon Contact Activation of Blood Coagulation : A Hypothesis , 1998 .

[36]  Shu‐wen W. Chen,et al.  Identification of functionally important residues in proteins using comparative models. , 2004, Current medicinal chemistry.

[37]  David N. Ku,et al.  A Mechanistic Model of Acute Platelet Accumulation in Thrombogenic Stenoses , 2001, Annals of Biomedical Engineering.

[38]  F. Ataullakhanov,et al.  Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate * , 2005, Journal of thrombosis and haemostasis : JTH.

[39]  Osman Güner,et al.  Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. , 2004, Current medicinal chemistry.

[40]  Mikhail A Panteleev,et al.  Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. , 2006, Biophysical journal.

[41]  H. Roberts,et al.  Platelet-dependent action of high-dose factor VIIa. , 2002, Blood.

[42]  Hans Gregersen,et al.  Dynamic model of the role of platelets in the blood coagulation system. , 2002, Medical engineering & physics.

[43]  V. Turitto,et al.  Platelet deposition on subendothelium exposed to flowing blood: mathematical analysis of physical parameters. , 1975, Transactions - American Society for Artificial Internal Organs.

[44]  G D Stubley,et al.  Theoretical and experimental analysis of cellular adhesion to polymer surfaces. , 1987, Journal of biomedical materials research.

[45]  T David,et al.  The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow. , 2004, Biorheology.

[46]  H. Hemker,et al.  Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk. , 2004, Thrombosis research.

[47]  Sharene D. Bungay,et al.  A mathematical model of lipid-mediated thrombin generation. , 2003, Mathematical medicine and biology : a journal of the IMA.

[48]  S. Béguin,et al.  Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time , 2004, Journal of thrombosis and haemostasis : JTH.

[49]  D. A. Molchanova,et al.  [A simulated mathematical model of the blood coagulation system intrinsic pathway]. , 1995, Biofizika.

[50]  D. Basmadjian,et al.  An analysis of the contact phase of blood coagulation: Effects of shear rate and surface are intertwined , 1994, Annals of Biomedical Engineering.

[51]  Shmuel Einav,et al.  Dynamics of Blood Flow and Platelet Transport in Pathological Vessels , 2004, Annals of the New York Academy of Sciences.

[52]  E. Neshkova,et al.  Contact System. New Concepts on Activation Mechanisms and Bioregulatory Functions , 2004, Biochemistry (Moscow).

[53]  K. Mann,et al.  Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. , 2000, Blood.

[54]  M A Khanin,et al.  Mathematical model for the blood coagulation prothrombin time test. , 1998, Thrombosis research.

[55]  R. Storey.  Biology and pharmacology of the platelet P2Y12 receptor. , 2006, Current pharmaceutical design.

[56]  Piet Hemker,et al.  Mathematical modelling in blood coagulation ; Simulation and parameter estimation , 1997 .

[57]  F Keller,et al.  The quick machine--a mathematical model for the extrinsic activation of coagulation. , 1994, Haemostasis.

[58]  M. Packham.  The Behavior of Platelets at Foreign Surfaces , 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[59]  X. H. Xu,et al.  The kinetic model and simulation of blood coagulation--the kinetic influence of activated protein C. , 2004, Medical engineering & physics.

[60]  Edward F. Leonard,et al.  Effects of Shear Rate on the Diffusion and Adhesion of Blood Platelets to a Foreign Surface , 1972 .

[61]  A. V. Pokhilko,et al.  Contact activation of blood coagulation: trigger properties and hysteresis. Kinetic recognition of foreign surfaces upon contact activation of blood coagulation: a hypothesis. , 1998, Journal of theoretical biology.

[62]  Diran Basmadjian,et al.  The effect of flow and mass transport in thrombogenesis , 2006, Annals of Biomedical Engineering.

[63]  K. C. Jones,et al.  A Model for the Stoichiometric Regulation of Blood Coagulation* , 2002, The Journal of Biological Chemistry.

[64]  U. Hedner.  Recombinant factor VIIa (NovoSeven) as a hemostatic agent. , 2001, Disease-a-month : DM.

[65]  Thomas Orfeo,et al.  The Significance of Circulating Factor IXa in Blood* , 2004, Journal of Biological Chemistry.

[66]  M A Khanin,et al.  Analysis of the activated partial thromboplastin time test using mathematical modeling. , 2001, Thrombosis research.

[67]  D Basmadjian,et al.  Embolization: critical thrombus height, shear rates, and pulsatility. Patency of blood vessels. , 1989, Journal of biomedical materials research.

[68]  R. Colman,et al.  Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 1988 .

[69]  M. Erion,et al.  Computer-aided drug design strategies used in the discovery of fructose 1, 6-bisphosphatase inhibitors. , 2005, Current pharmaceutical design.

[70]  C. Watała.  Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. , 2005, Current pharmaceutical design.

[71]  K. Mann,et al.  Mechanism of factor VIIa-dependent coagulation in hemophilia blood. , 2002, Blood.

[72]  T. Lindahl,et al.  A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy , 2003, Pathophysiology of Haemostasis and Thrombosis.

[73]  Thomas Orfeo,et al.  The Tissue Factor Requirement in Blood Coagulation* , 2005, Journal of Biological Chemistry.

[74]  R J Leipold,et al.  Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin (*) , 1995, The Journal of Biological Chemistry.

[75]  H. Nagashima.  Studies on the Different Modes of Action of the Anticoagulant Protease Inhibitors DX-9065a and Argatroban , 2002, The Journal of Biological Chemistry.

[76]  K. Mann,et al.  The Regulation of the Factor VII-Dependent Coagulation Pathway: Rationale for the Effectiveness of Recombinant Factor VIIa in Refractory Bleeding Disorders , 2000, Seminars in thrombosis and hemostasis.

[77]  Jae-Woo Lee.  von Willebrand Disease, Hemophilia A and B, and Other Factor Deficiencies , 2004, International anesthesiology clinics.

[78]  D. Monroe,et al.  Mechanism of action of high-dose factor VIIa: points of agreement and disagreement. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[79]  Mikhail V Ovanesov,et al.  Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. , 2002, Biochimica et biophysica acta.

[80]  M. Berndt,et al.  Platelet physiology and thrombosis. , 2004, Thrombosis research.

[81]  Mikhail A Panteleev,et al.  Tissue factor pathway inhibitor: a possible mechanism of action. , 2002, European journal of biochemistry.

[82]  E. Beltrami,et al.  Positive feedbacks of coagulation: their role in threshold regulation. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[83]  I A Feuerstein,et al.  Platelet transport and adhesion to reconstituted collagen and artificial surfaces,. , 1975, Transactions - American Society for Artificial Internal Organs.